Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate
September 12, 2024
Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that the California Institute for Regenerative Medicine (CIRM) had awarded a $3.8M grant to support the development of a next-generation neural cell therapy candidate.
Cory Nicholas, PhD, was the lead UCSF inventor.